Joseph M. Jr. Manko Buys 77,600 Shares of Repro-Med Systems, Inc. (REPR) Stock

Repro-Med Systems, Inc. (OTCMKTS:REPR) Director Joseph M. Jr. Manko purchased 77,600 shares of Repro-Med Systems stock in a transaction that occurred on Thursday, November 30th. The stock was purchased at an average price of $0.82 per share, with a total value of $63,632.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.

Repro-Med Systems, Inc. (REPR) traded down $0.03 on Friday, reaching $0.84. The company had a trading volume of 44,401 shares, compared to its average volume of 54,039. Repro-Med Systems, Inc. has a twelve month low of $0.34 and a twelve month high of $0.86.

COPYRIGHT VIOLATION NOTICE: “Joseph M. Jr. Manko Buys 77,600 Shares of Repro-Med Systems, Inc. (REPR) Stock” was first posted by Community Financial News and is owned by of Community Financial News. If you are reading this story on another domain, it was illegally stolen and reposted in violation of United States & international copyright & trademark legislation. The original version of this story can be read at https://www.com-unik.info/2017/12/03/joseph-m-jr-manko-buys-77600-shares-of-repro-med-systems-inc-repr-stock.html.

Repro-Med Systems Company Profile

REPRO MED SYSTEMS, INC. (RMS) designs, manufactures and markets medical devices for the ambulatory infusion market and emergency medical applications. The Company’s products include FREEDOM60 Syringe Infusion System (FREEDOM60), RMS HIGH-Flo Subcutaneous Safety Needle Sets (HIgH-Flo), RES-Q-VAC Portable Medical Suction System (RES-Q-VAC) and On-Line Calculator.

Insider Buying and Selling by Quarter for Repro-Med Systems (OTCMKTS:REPR)

What are top analysts saying about Repro-Med Systems Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Repro-Med Systems Inc. and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit